The Asia Pacific Intravenous Immunoglobulin Market would witness market growth of 7.8% CAGR during the forecast period (2022-2028).
The term immunoglobulin refers to the breakdown of antibody-containing blood plasma. IVIg (intravenous immunoglobulin) is a blood product that is given intravenously. It's made up of polyvalent IgG antibodies collected from the plasma of thousands of blood donors. Patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia, and other kinds of hypogammaglobulinemia who are unable to make significant amounts of antibodies, get benefit from IVIg to maintain the right amount of antibodies in the body.
The comprehensive market for IVIg is divided into two categories i.e. plasma protein and therapeutic area. Polyvalent IVIg, albumin, Factor VIII, hyperimmune (IM&IV), and Factor IX are all part of the plasma protein. Immune deficiencies, autoimmune disorders, and acute infections are also included in the therapeutic area segment. The immune deficiency includes important disorders with low antibody levels, such as hypogammaglobulinemia (primary immune deficiencies), X-linked agammaglobulinemia (secondary immune deficiencies), and acquired weakened immunity syndromes (secondary immunological deficiencies). Immune thrombocytopenia and inflammatory disorders are two types of autoimmune illnesses.
The regional government and medical association are making efforts to strengthen the healthcare infrastructure in order to suit newly brought medical technology like intravenous immunoglobulin. The Ministry of Education, the Central Committee of the Communist Youth League, the State Ethnic Affairs Commission, among others, conducted different kinds of publicity and education activities for the AIDS response, depending on the respective work advantages and concentrating on such groups as teenagers, migrant workers, and women. In terms of prevention and treatment, the percentage of female sex workers living with HIV has remained relatively low in recent years.
The China market dominated the Asia Pacific Intravenous Immunoglobulin Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,150.2 million by 2028. The Japan market is poised to grow at CAGR of 7.1% during (2022 - 2028). Additionally, The India market would display a CAGR of 8.5% during (2022 - 2028).
Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Specialty Pharmacy, and Others. Based on Application, the market is segmented into Immunodeficiency Diseases, Chronic Inflammatory Demyelinating Polyneuropathy, Hypogammaglobulinemia, Chronic Lymphocytic Leukemia & Myasthenia Gravis, Congenital AIDS & Multifocal Motor Neuropathy, Kawasaki Disease, Guillain-Barre Syndrome, Immune thrombocytopenia (ITP), and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Intravenous Immunoglobulin Market is Projected to reach USD 17.3 Billion by 2028, at a CAGR of 6.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Grifols, S.A., Takeda Pharmaceutical Company Limited, Baxter International, Inc., Biotest AG (Tiancheng International Investment Limited), LFB S.A., CSL Limited (CSL Behring), Octapharma AG, Kedrion S.p.A, and Bayer AG.
Scope of the Study
Market Segments Covered in the Report:
By Distribution Channel
- Hospital Pharmacy
- Specialty Pharmacy
- Others
By Application
- Immunodeficiency Diseases
- Chronic Inflammatory Demyelinating Polyneuropathy
- Hypogammaglobulinemia
- Chronic Lymphocytic Leukemia & Myasthenia Gravis
- Congenital AIDS & Multifocal Motor Neuropathy
- Kawasaki Disease
- Guillain-Barre Syndrome
- Immune thrombocytopenia (ITP)
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Grifols, S.A.
- Takeda Pharmaceutical Company Limited
- Baxter International, Inc.
- Biotest AG (Tiancheng International Investment Limited)
- LFB S.A.
- CSL Limited (CSL Behring)
- Octapharma AG
- Kedrion S.p.A
- Bayer AG
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Intravenous Immunoglobulin Market, by Distribution Channel
1.4.2 Asia Pacific Intravenous Immunoglobulin Market, by Application
1.4.3 Asia Pacific Intravenous Immunoglobulin Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel
3.1 Asia Pacific Hospital Pharmacy Market by Country
3.2 Asia Pacific Specialty Pharmacy Market by Country
3.3 Asia Pacific Others Market by Country
Chapter 4. Asia Pacific Intravenous Immunoglobulin Market by Application
4.1 Asia Pacific Immunodeficiency Diseases Market by Country
4.2 Asia Pacific Chronic Inflammatory Demyelinating Polyneuropathy Market by Country
4.3 Asia Pacific Hypogammaglobulinemia Market by Country
4.4 Asia Pacific Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country
4.5 Asia Pacific Congenital AIDS & Multifocal Motor Neuropathy Market by Country
4.6 Asia Pacific Kawasaki Disease Market by Country
4.7 Asia Pacific Guillain-Barre Syndrome Market by Country
4.8 Asia Pacific Immune thrombocytopenia (ITP) Market by Country
4.9 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Intravenous Immunoglobulin Market by Country
5.1 China Intravenous Immunoglobulin Market
5.1.1 China Intravenous Immunoglobulin Market by Distribution Channel
5.1.2 China Intravenous Immunoglobulin Market by Application
5.2 Japan Intravenous Immunoglobulin Market
5.2.1 Japan Intravenous Immunoglobulin Market by Distribution Channel
5.2.2 Japan Intravenous Immunoglobulin Market by Application
5.3 India Intravenous Immunoglobulin Market
5.3.1 India Intravenous Immunoglobulin Market by Distribution Channel
5.3.2 India Intravenous Immunoglobulin Market by Application
5.4 South Korea Intravenous Immunoglobulin Market
5.4.1 South Korea Intravenous Immunoglobulin Market by Distribution Channel
5.4.2 South Korea Intravenous Immunoglobulin Market by Application
5.5 Singapore Intravenous Immunoglobulin Market
5.5.1 Singapore Intravenous Immunoglobulin Market by Distribution Channel
5.5.2 Singapore Intravenous Immunoglobulin Market by Application
5.6 Malaysia Intravenous Immunoglobulin Market
5.6.1 Malaysia Intravenous Immunoglobulin Market by Distribution Channel
5.6.2 Malaysia Intravenous Immunoglobulin Market by Application
5.7 Rest of Asia Pacific Intravenous Immunoglobulin Market
5.7.1 Rest of Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel
5.7.2 Rest of Asia Pacific Intravenous Immunoglobulin Market by Application
Chapter 6. Company Profiles
6.1 Grifols, S.A
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional & Segmental Analysis
6.1.4 Research & Development Expenses
6.1.5 Recent strategies and developments:
6.1.5.1 Product Launches and Product Expansions:
6.1.5.2 Acquisition and Mergers:
6.2 Takeda Pharmaceutical Company Limited
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Approvals and Trials:
6.3 Baxter International, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional Analysis
6.3.4 Research & Development Expense
6.4 Biotest AG (Tiancheng International Investment Limited)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 LFB S.A.
6.5.1 Company Overview
6.5.2 Recent strategies and developments:
6.5.2.1 Partnerships, Collaborations, and Agreements:
6.6 CSL Limited (CSL Behring)
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Octapharma AG
6.7.1 Company Overview
6.7.2 Recent strategies and developments:
6.7.2.1 Approvals and Trials:
6.8 Kedrion S.p.A
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expenses
6.9 Bayer AG
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
TABLE 1 Asia Pacific Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Specialty Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Specialty Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Immunodeficiency Diseases Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Immunodeficiency Diseases Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Chronic Inflammatory Demyelinating Polyneuropathy Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Chronic Inflammatory Demyelinating Polyneuropathy Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Hypogammaglobulinemia Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Hypogammaglobulinemia Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Congenital AIDS & Multifocal Motor Neuropathy Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Congenital AIDS & Multifocal Motor Neuropathy Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Kawasaki Disease Market by Country, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Kawasaki Disease Market by Country, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Guillain-Barre Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Guillain-Barre Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Immune thrombocytopenia (ITP) Market by Country, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Immune thrombocytopenia (ITP) Market by Country, 2022 - 2028, USD Million
TABLE 29 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 30 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 31 Asia Pacific Intravenous Immunoglobulin Market by Country, 2018 - 2021, USD Million
TABLE 32 Asia Pacific Intravenous Immunoglobulin Market by Country, 2022 - 2028, USD Million
TABLE 33 China Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 34 China Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 35 China Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 36 China Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 37 China Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 38 China Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 39 Japan Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 40 Japan Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 41 Japan Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 42 Japan Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 43 Japan Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 44 Japan Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 45 India Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 46 India Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 47 India Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 48 India Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 49 India Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 50 India Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 51 South Korea Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 52 South Korea Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 53 South Korea Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 54 South Korea Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 55 South Korea Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 56 South Korea Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 57 Singapore Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 58 Singapore Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 59 Singapore Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 60 Singapore Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 61 Singapore Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 62 Singapore Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 63 Malaysia Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 64 Malaysia Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 65 Malaysia Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 66 Malaysia Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 67 Malaysia Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 68 Malaysia Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 69 Rest of Asia Pacific Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
TABLE 70 Rest of Asia Pacific Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
TABLE 71 Rest of Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 72 Rest of Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 73 Rest of Asia Pacific Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
TABLE 74 Rest of Asia Pacific Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
TABLE 75 Key information – Grifols, S.A.
TABLE 76 Key Information – Takeda Pharmaceutical Company Limited
TABLE 77 Key Information – Baxter International, Inc.
TABLE 78 key information – Biotest AG
TABLE 79 Key Information – LFB S.A
TABLE 80 key Information – CSL Limited
TABLE 81 Key Information – Octapharma AG
TABLE 82 key Information – Kedrion S.p.A
TABLE 83 Key Information – Bayer AG
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Grifols, S.A.